JPRN-jRCT2080222305未知1 期
Phase 1 Clinical Study of TS-071 in Healthy Male Adults (Repeated Administration)
Taisho Pharmaceutical co., LTD0 个研究点目标入组 24 人开始时间: 2013年11月21日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 39age old（—）
- 性别
- Male
入选标准
- •Healthy Japanese male subjects
排除标准
- •Subjects with cardiovascular disorder, hepatic/biliary disorder, gastrointestinal disorder, urological disorder, renal disorder, endocrine disorder, immunological disorder, malignant tumor, diabetes mellitus, abnormal glucose tolerance, or respiratory disorder (such as pulmonary disease)
研究者
相似试验
未知
1 期
Phase 1 Clinical Study of TS-071 in Healthy Adult Male Subjects (Single-Dose Administration)Healthy Japanese male subjectsJPRN-jRCT2080222304Taisho Pharmaceutical co., LTD57
未知
4 期
Clinical Pharmaclogical study of TS-071 in Patient With Type 2 Diabetetes Mellitus(Evaluation of glycemic variability using continuous glucose monitoring)Type 2 Diabetes MellitusJPRN-jRCT1080222497Taisho Pharmaceutical co., LTD40
未知
1 期
Phase I sutdy of TMS-007Acute ischemic strokeJPRN-jRCT2080222603TMS Co., Ltd.40
已完成
1 期
Phase1 Study of TS-141 in Healthy Volunteers-JPRN-jRCT2080225139Taisho Pharmaceutical Co.Ltd48
未知
2 期
Double-blind, Phase2 Study of TS-071 in Patients With Type 2 Diabetes Mellitus (Confirmatory Study of Dose-Response)Type 2 Diabetes MellitusJPRN-jRCT2080221156Taisho Pharmaceutical co., LTD275